Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

被引:13
|
作者
Terai, Mizue [1 ]
Shimada, Ayako [2 ]
Chervoneva, Inna [2 ]
Hulse, Liam [1 ]
Danielson, Meggie [1 ]
Swensen, Jeff [3 ]
Orloff, Marlana [1 ]
Wedegaertner, Philip B. [4 ]
Benovic, Jeffrey L. [4 ]
Aplin, Andrew E. [5 ]
Sato, Takami [1 ]
机构
[1] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[3] Caris Life Sci, Mol Genet, Phoenix, AZ 85040 USA
[4] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA
关键词
uveal melanoma; metastasis; metastatic uveal melanoma; survival; GNA11; GNAQ; Q209P; Q209L; BAP1; SF3B1; ONCOGENIC MUTATIONS; GNAQ; SURVIVAL;
D O I
10.3390/cancers13225749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. More than 90% of UMs harbor mutually exclusive activating mutations in G-proteins. The mutations are early events in UM development and considered to be driver mutations in carcinogenesis. Even after treatment of primary uveal melanoma, up to 50% of patients subsequently develop recurrence, predominantly in the liver. GNAQ mutations are not reported to be correlated to survival, while the mutations in GNA11 are reported more frequently in metastatic UM. We investigated the correlation of survival after development of metastasis (Met-to-Death) of metastatic uveal melanoma (MUM) patients with GNA11 and GNAQ mutations. We identified that MUM with mutation patterns of Q209P vs. Q209L in GNA11 and GNAQ might predict survival of MUM patients. Uveal melanoma is the most common primary ocular malignancy in adults, characterized by gene mutations in G protein subunit alpha q (GNAQ) and G protein subunit alpha 11 (GNA11). Although they are considered to be driver mutations, their role in MUM remains elusive. We investigated key somatic mutations ofMUM and their impact on patients' survival after development of systemic metastasis (Met-to-Death). Metastatic lesions from 87 MUM patients were analyzed by next generation sequencing (NGS). GNA11 (41/87) and GNAQ (39/87) mutations were most predominantly seen in MUM. Most GNA11 mutations were Q209L (36/41), whereas GNAQ mutations comprised Q209L (14/39) and Q209P (21/39). Epigenetic pathway mutations BAP1 (42/66), SF3B1 (11/66), FBXW7 (2/87), PBRM1 (1/66), and SETD2 (1/66) were found. No specimen had the EIF1AX mutation. Interestingly, Met-to-Death was longer in patients with GNAQ Q209P compared to GNAQ/GNA11 Q209L mutations, suggesting the difference in mutation type in GNAQ/GNA11 might determine the prognosis of MUM. Structural alterations of the GNAQ/GNA11 protein and their impact on survival of MUM patients should be further investigated.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] G-Protein β Subunit Mutations in Sinus Node Dysfunction
    Lodder, Elisabeth M.
    Verkerk, Arie O.
    Bezzina, Connie R.
    CIRCULATION RESEARCH, 2017, 120 (10) : 1524 - 1526
  • [32] Genetics of pituitary tumors: Focus on G-protein mutations
    Lania, A
    Mantovani, G
    Spada, A
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (09) : 1004 - 1017
  • [33] Prognostic Value of BAP1 Protein Expression in Uveal Melanoma
    Kennedy, Susan
    Owens, Sally
    Ivers, Laura
    Hegarty, Ciara
    O'Neill, Valerie
    Berenguer-Pina, Jose J.
    Horgan, Noel
    Crown, John
    Walsh, Naomi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (03) : 329 - 336
  • [34] Therapy of metastatic malignant uveal melanoma
    Jäckel, A
    Bock, M
    Deichmann, M
    Waldmann, V
    Näher, H
    HAUTARZT, 2001, 52 (02): : 98 - 103
  • [35] The genetic evolution of metastatic uveal melanoma
    A. Hunter Shain
    Mette M. Bagger
    Richard Yu
    Darwin Chang
    Shanshan Liu
    Swapna Vemula
    Jingly F. Weier
    Karin Wadt
    Steffen Heegaard
    Boris C. Bastian
    Jens F. Kiilgaard
    Nature Genetics, 2019, 51 : 1123 - 1130
  • [36] Lack of BRAF mutations in uveal melanoma
    Rimoldi, D
    Salvi, S
    Liénard, D
    Lejeune, FJ
    Speiser, D
    Zografos, L
    Cerottini, JC
    CANCER RESEARCH, 2003, 63 (18) : 5712 - 5715
  • [37] Effectiveness of Treatments for Metastatic Uveal Melanoma
    Augsburger, James J.
    Correa, Zelia M.
    Shaikh, Adeel H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (01) : 119 - 127
  • [38] Variates of survival in metastatic uveal melanoma
    Rietschel, P
    Panageas, KS
    Hanlon, C
    Patel, A
    Abramson, DH
    Chapman, PB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8076 - 8080
  • [39] Transhepatic Therapies for Metastatic Uveal Melanoma
    Eschelman, David J.
    Gonsalves, Carin F.
    Sato, Takami
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2013, 30 (01) : 39 - 48
  • [40] The genetic evolution of metastatic uveal melanoma
    Shain, A. Hunter
    Bagger, Mette M.
    Yu, Richard
    Chang, Darwin
    Liu, Shanshan
    Vemula, Swapna
    Weier, Jingly F.
    Wadt, Karin
    Heegaard, Steffen
    Bastian, Boris C.
    Kiilgaard, Jens F.
    NATURE GENETICS, 2019, 51 (07) : 1123 - +